FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Neville Everett
2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2021 

3. Issuer Name and Ticker or Trading Symbol

Cigna Corp [CI]
(Last)        (First)        (Middle)

900 COTTAGE GROVE ROAD
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
EVP, Strategy and Business Dev /
(Street)

BLOOMFIELD, CT 06002      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $.01 Par Value 7371.0000 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy) 2/28/2016 (1)3/4/2025 Common Stock, $.01 Par Value 192.0000 $176.6556 D  
Employee Stock Option (Right to Buy) 2/26/2021 (2)2/26/2030 Common Stock, $.01 Par Value 8340.0000 $192.0200 D  
Phantom Stock Units (3) (4) (4)Common Stock, $.01 Par Value 418.6865 (3)$0.0000 (5)D  

Explanation of Responses:
(1) This option is fully vested.
(2) This option vests in three equal annual installments beginning February 26, 2021.
(3) Phantom Stock Units credited under Express Scripts Executive Deferred Compensation Plan.
(4) These Phantom Stock Units are fully vested.
(5) Upon distribution, each Phantom Stock Unit converts to one share of Cigna Corporation Common Stock.

Remarks:
Exhibit 24 - Power of Attorney poaneville.txt

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Neville Everett
900 COTTAGE GROVE ROAD
BLOOMFIELD, CT 06002


EVP, Strategy and Business Dev

Signatures
By: Jill M. Stadelman, attorney-in-fact1/8/2021
**Signature of Reporting PersonDate

Cigna (NYSE:CI)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Cigna Charts.
Cigna (NYSE:CI)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Cigna Charts.